Udomsak Udomnilobol

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Emergency Department

Cancer Stem Cells

Top Venues

Drug metabolism and disposition: the biological fate of chemicals

Pharmacogenomics and personalized medicine

Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR)

Chulalongkorn University Faculty of Pharmaceutical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR) Jul 1o 2017

Thailand

Researcher :: Drug Metabolism and Pharmacokinetics (DMPK) Unit

Education History

Chulalongkorn University Faculty of Pharmaceutical Sciences

Thailand

PHD :: Pharmacology and Toxicology

Publications

Udomsak Udomnilobol, Suree Jianmongkol, Thomayant Prueksaritanont
The Potentially Significant Role of CYP3A-Mediated Oxidative Metabolism of Dabigatran Etexilate and its Intermediate Metabolites in Drug-Drug Interaction Assessments Using Microdose Dabigatran Etexilate . Drug metabolism and disposition: the biological fate of chemicals (2023)
Tanachote Ruengsatra, Arthitaya Meeprasert, Eakkaphon Rattanangkool, Sirikan Deesiri, Jakkrit Srisa, Udomsak Udomnilobol, Wilasinee Dunkoksung, Natthaya Chuaypen, Rattanaporn Kiatbumrung, Pisit Tangkijvanich, Sornkanok Vimolmangkang, Khanitha Pudhom, Thomayant Prueksaritanont
Binding characteristics of pyrrole-scaffold hepatitis B virus capsid inhibitors and identification of novel potent compounds. RSC advances 13 (41) (2023)
Punyabhorn Rattanacheeworn, Monpat Chamnanphon, Siriwan Thongthip, Wonngarm Kittanamongkolchai, Natavudh Townamchai, Yingyos Avihingsanon, Udomsak Udomnilobol, Thomayant Prueksaritanont, Suree Jianmongkol, Pajaree Chariyavilaskul
SLCO1B1 and ABCG2 Gene Polymorphisms in a Thai Population. Pharmacogenomics and personalized medicine 13 (2020)